Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agent of heartworm disease

Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agent of heartworm disease

US Patent 10000811 · Granted Jun 19, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2025
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2025
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2025
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2022
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2022
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2022
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Macrocyclic lactone resistance marker for dirofilaria immitis2014
Macrocyclic lactone resistance marker for dirofilaria immitis2014
Macrocyclic lactone resistance marker for dirofilaria immitis2014
Anthelmintic combination2013